Your browser doesn't support javascript.
loading
The Landmark Series: Multimodal Therapy for Esophageal Cancer.
Demarest, Caitlin T; Chang, Andrew C.
Afiliação
  • Demarest CT; Section of Thoracic Surgery, Department of Surgery, Michigan Medicine, Ann Arbor, MI, USA.
  • Chang AC; Section of Thoracic Surgery, Department of Surgery, Michigan Medicine, Ann Arbor, MI, USA. andrwchg@umich.edu.
Ann Surg Oncol ; 28(6): 3375-3382, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33629251
INTRODUCTION: Esophagectomy is the mainstay of treatment for patients with resectable esophageal cancer, and chemotherapy and chemoradiation have become essential adjuncts to improve survival. Controversy remains regarding the optimal perioperative therapy. METHODS: This review focuses on three landmark, randomized, controlled trials that have greatly influenced esophageal cancer management and established chemotherapy and chemoradiotherapy as standard of care: Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial (MAGIC); The United Kingdom Medical Research Council Esophageal Cancer Trial (OEO2); and Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS). RESULTS: The findings from these landmark studies are reviewed and summarized. CONCLUSION: Chemotherapy regimens are heterogeneous but centered around platinum-based therapy and should be included in the management for all appropriate patients. Ongoing and future studies will further delineate the roles of various chemo- and chemoradiotherapy regimens and also will investigate the promising area of immunotherapy in the treatment of esophageal cancer.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos